Evidence map›Paper›PMID 41939909›Full record

ArticleFrontiers in immunology2026

Estimating time since influenza virus exposure using single-cell proteomic data.

Klodiana Rizzo Nervo, Neda Hajiakhoond Bidoki, Han Chen, Zainab Rahil, Zach Bjornson, Kenneth Kim, Bonnie Bock, Melton Affrime, Logan Bauerle, Pham Bao Tran Huynh and 6 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Klodiana Rizzo Nervo *Department of Microbiology and Immunology, School of Medicine, University of Nevada, Reno, Reno, NV, United States.
Neda Hajiakhoond Bidoki *Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Han ChenDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, United States.
Zainab RahilDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, United States.
Zach BjornsonDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, United States.
Kenneth KimArk Clinical Research, LLC, Long Beach, CA, United States.
Bonnie BockWCCT Global, Cypress, CA, United States.
Melton AffrimeWCCT Global, Cypress, CA, United States.
Logan BauerleDepartment of Microbiology and Immunology, School of Medicine, University of Nevada, Reno, Reno, NV, United States.
Pham Bao Tran HuynhDepartment of Microbiology and Immunology, School of Medicine, University of Nevada, Reno, Reno, NV, United States.
David LiebowitzVaxart, Inc., South San Francisco, CA, United States.
Sean TuckerVaxart, Inc., South San Francisco, CA, United States.
Pier Federico GherardiniDepartment of Biology, University of Rome "Tor Vergata", Rome, Italy.
Garry P NolanDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
Nima AghaeepourDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, United States.
David R McIlwainDepartment of Microbiology and Immunology, School of Medicine, University of Nevada, Reno, Reno, NV, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Determining when the onset of a respiratory infection occurred is important for effective clinical management and can aid in mapping transmission events. However, current diagnostic assays report only pathogen detection status and do not provide any information about the timing of infection, in part because of the lack of biomarkers that inform time since exposure. Methods: To address this gap, we developed immune-based predictive models of infection timing and shedding status using data from a controlled human challenge with influenza A/California/2009 (H1N1), in which major immune cell subsets were longitudinally profiled across multiple time points before and after viral challenge using 42-marker mass cytometry panels. Random forest machine learning models were trained to address two predictive objectives: (1) distinguishing virus shedders from non-shedders and (2) estimating days post-infection challenge (DPC) from immune profiles. Model performance was evaluated within the primary challenge cohort and independently validated using data from a separate controlled human influenza challenge study using the same virus. Results: Our analysis revealed that single-cell immune population dynamics alone encode a robust and reproducible temporal structure following influenza infection, enabling accurate estimation of virus exposure timing. Discussion: These findings provide foundational insight into host immune responses during influenza infection and represent an early step toward a future class of immune-based diagnostics that could extend beyond pathogen detection to inform infection timing and the duration of periods associated with contagiousness.

Indexed as

Influenza A Virus, H1N1 SubtypeInfluenza, HumanProteomicsSingle-Cell AnalysisBiomarkersHuman Challenge Trials as TopicHumansMachine LearningPredictive Learning ModelsTime FactorsVirus SheddingBiomarkerscontrolled human virus challengeinfluenza A (H1N1)machine learningmass cytometry (CyTOF)random forest models

Identifiers

PMID41939909
PMCPMC13044454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.